To investigate the clinical characteristics and long-term prognosis of patients with type 2 myocardial infarction (T2MI) among intensive care unit (ICU) survivors of sepsis.
Key Findings:
524 out of 1,469 sepsis patients with acute myocardial infarction were classified as T2MI.
T2MI patients received less frequent treatment with various cardiac medications compared to TIMI patients, with statistical significance noted.
T2MI was associated with a significantly higher risk of 5-year mortality (HR 1.469) and 6-month mortality (HR 1.527), both statistically significant.
Cumulative mortality rates varied by T2MI etiology, with anemia and hypoxemia being the most common triggers.
Interpretation:
T2MI in sepsis survivors is linked to poorer long-term outcomes, highlighting the need for targeted management strategies in this population to improve prognosis.
Limitations:
Retrospective nature may introduce selection bias.
Data sourced from a single database may limit generalizability.
Potential confounding factors not accounted for in the analysis.
Conclusion:
Hypoxemia and anemia are prevalent causes of T2MI in sepsis survivors, correlating with increased mortality risk at 6 months and 5 years, emphasizing the need for clinical attention.
